Home » Newsletters » BioWorld Science

BioWorld Science

July 10, 2002

View Archived Issues

Adenosine A3 receptor agonists: a novel class of anticancer agents

Antagonism of the glucocorticoid receptor as a possible approach to Alzheimer's disease

Glucagon antagonists or inverse agonists identified at Novo Nordisk and Agouron

Colesevelam improves LDL particle size distribution in moderate hypercholesterolemia

Breakthrough AIDS treatment ready for phase II clinical trials

Carrageenan-based microbicide PC-710 described at AIDS conference

NR2B-selective NMDA antagonists for the treatment of pain syndromes

Inspire presents melatonin analogues with IOP-reducing properties

Bladder-selective antimuscarinic agent from Roche in development for overactive bladder

Effective and safe new antithrombotic presented by Pfizer at IUPHAR 2002

SSR-182289: novel oral thrombin inhibitor with high potency and selectivity

Early clinical data discussed for the HIV integrase inhibitor S-1360

U.S. research group presents new antitumor camptothecins

Prostaglandin IP antagonists and their use in pain, etc.

Data from preclinical studies support further development of PA-344B

Immune type-selective proteasome inhibitors identified at Kyorin

Wyeth claims dual 5-HT1A/SERT modulators

New anxiolytic/antidepressant agents under study at Ortho-McNeil

Novel CRF antagonists in early development at Neurocrine Biosciences

PRO-2000 proves safe, achieves potentially protective levels in women

Enzyme replacement therapy for Fabry's disease to be reviewed by advisory committee

Large Scale Biology enters collaboration for developing plant-derived vaccines

Amgen and Immunex grant license to Regeneron

AstraZeneca completes mutual recognition procedure for pediatric use of Symbicort Turbuhaler